Predictors of Graft Function Improvement after Conversion from Calcineurin Inhibitors to Belatacept in Kidney Recipients with Calcineurin Inhibitor Nephrotoxicity.

被引：0
|
作者：
Viglietti, D. [1 ]
Pievani, D. [1 ]
Louis, K. [1 ]
Glotz, D. [1 ]
Legendre, C. [1 ]
Loupy, A. [1 ]
Lefaucheur, C. [1 ]
机构：
[1] Paris Translat Res Ctr Organ Transplantat, Paris, France
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2019年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
311
引用
收藏
页码：450 / 450
页数：1
相关论文
共 50 条
  • [21] Late Conversion From Calcineurin Inhibitors to Belatacept in Kidney-Transplant Recipients Has a Significant Beneficial Impact on Glycemic Parameters
    Terrec, Florian
    Jouve, Thomas
    Naciri-Bennani, Hamza
    Benhamou, Pierre-Yves
    Malvezzi, Paolo
    Janbon, Benedicte
    Giovannini, Diane
    Rostaing, Lionel
    Noble, Johan
    [J]. TRANSPLANTATION DIRECT, 2020, 6 (01): : E517
  • [22] Conversion from calcineurin inhibitors to everolimus in kidney transplant recipients with malignant neoplasia
    Fernandez, A.
    Marcen, R.
    Pascual, J.
    Galeano, C.
    Ocana, J.
    Arellano, E. M.
    Alfaro, C.
    Villafruela, J. J.
    Burgos, F. J.
    Ortuno, J.
    [J]. TRANSPLANTATION PROCEEDINGS, 2006, 38 (08) : 2453 - 2455
  • [23] Clinical Outcomes of Conversion from Calcineurin Inhibitor to Belatacept-Based Immunosuppression in Highly Sensitized Kidney Transplant Recipients.
    Sethi, S.
    Choi, J.
    Vo, A.
    Peng, A.
    Lim, K.
    Najjar, R.
    Jordan, S.
    Huang, E.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 291 - 292
  • [24] Late Conversion from Calcineurin Inhibitors to Belatacept in Kidney-Transplant Recipients Has a Significant Beneficial Impact on Glycemic Parameters
    Noble, J.
    Terrec, F.
    Jouve, T.
    Bennani, H. Neciri
    Benhamou, P.
    Malvezzi, P.
    Janbon, B.
    Giovannini, D.
    Rostaing, L.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 927 - 927
  • [25] CONVERSION FROM CALCINEURIN INHIBITORS TO BELATACEPT IN KIDNEY RECIPIENTS DECREASES THE PATHOGENICITY OF DONOR-SPECIFIC ANTI-HLA ANTIBODIES
    Viglietti, Denis
    Louis, Kevin
    Pievani, Daniele
    Van Huyen, Jean-Paul Duong
    Aubert, Olivier
    Glotz, Denis
    Legendre, Christophe
    Loupy, Alexandre
    Zeevi, Adriana
    Lefaucheur, Carmen
    [J]. TRANSPLANT INTERNATIONAL, 2019, 32 : 81 - 81
  • [26] Renal function in renal or liver transplant recipients after conversion from a calcineurin inhibitor to sirolimus
    Backman, L
    Reisæter, AV
    Wramner, L
    Ericzon, BG
    Salmela, K
    Brattström, C
    [J]. CLINICAL TRANSPLANTATION, 2006, 20 (03) : 336 - 339
  • [27] Unexpected Early Calcineurin Inhibitor Nephrotoxicity in Pediatric Kidney Transplant Recipients.
    Yanik, M.
    Mannon, R.
    Seifert, M.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 750 - 750
  • [28] Switching from calcineurin inhibitors to belatacept decreases keratinocyte carcinomas incidence rate in kidney transplant recipients
    Wang, M.
    Mittal, A.
    Colegio, O.
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2019, 139 (05) : S92 - S92
  • [29] Renal function after liver transplantation: Calcineurin inhibitor nephrotoxicity
    Ziolkowski, J
    Paczek, L
    Senatorski, G
    Niewczas, M
    Oldakowska-Jedynak, U
    Wyzgal, J
    Sanko-Resmer, J
    Pilecki, T
    Zieniewicz, K
    Nyckowski, P
    Patkowski, W
    Krawczyk, M
    [J]. TRANSPLANTATION PROCEEDINGS, 2003, 35 (06) : 2307 - 2309
  • [30] Use of Belatacept as Rescue in Kidney Graft Recipients With Intolerance to Calcineurin Inhibitors: A French Multicenter Report of 36 Cases.
    Le Meur, Y.
    Aulagnon, F.
    Bertrand, D.
    Heng, A.
    Lavaud, S.
    Caillard, S.
    Longuet, H.
    Grall, A.
    Legendre, C.
    [J]. TRANSPLANTATION, 2014, 98 : 543 - 543
12345